PBC
Dược phẩm Trung ương I - Pharbaco ·UPCOM ·2026Q1
▼▼ Declining sharply
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, PBC is going through a period of clear decline across multiple metrics at once — the growth momentum has held across consecutive periods. What still needs to be determined is whether the business can find a stabilization point in the near term, or whether current pressure has not yet run its course.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 207.9 | 280.2 | 288.4 | 289.5 | 220.4 | 322.8 | 240.2 | 263.4 | 238.6 | 357.8 | 371.9 | 312.3 |
| Growth | -26% | -3% | -0% | +31% | -32% | +34% | -9% | +10% | -33% | -4% | +19% | — |
| Net Income | 10.7 | 6.4 | 22.4 | -5.2 | 19.7 | 6.5 | 15.6 | 8.5 | 13.7 | 0.7 | 15.6 | 8.6 |
| Net Margin | 5.13% | 2.29% | 7.76% | -1.78% | 8.93% | 2.02% | 6.51% | 3.23% | 5.75% | 0.19% | 4.20% | 2.76% |
Drivers of PBC's profit
Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to higher finance costs. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from 3.9% to 2.6% — leverage weakened the most, though asset turnover still provided support.
Is the profit sustainable?
Margins narrowed but earnings quality remains clean — pressure is mainly operational.
What is driving the margin?
Net margin fell to 3.22%, losing 1.6pp. The main pressure is Gross margin fell 2.3pp, outweighing the improvement in SG&A / Revenue fell 1.5pp (in addition, Other profit / Revenue rose 0.6pp added support while Net financial result / Revenue fell 1.4pp remained a drag).
Margin is under pressure from multiple sides — temporary and structural components need to be separated to properly assess the risk.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.
Is capital being deployed efficiently?
Track how much operating profit the business generates on invested capital.
Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC above should be read with industry context — the balance sheet below adds perspective. Leverage is elevated, requiring monitoring — liabilities at 1.42x equity, net debt at 1.10x equity.
Over the last 12 months, working capital absorbed 76.0bn of cash, mainly because of higher receivables and lower payables. Part of that drag was offset by lower inventories.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 31.1 days versus the same period last year. The main moves came from DIO fell 23.0 days, DSO fell 2.9 days, and DPO rose 5.3 days.
All 3 drivers (collection, inventory, payables) are improving — working capital turnover is strengthening across the board.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Leverage is safe but FCF is negative at 88.8bn due to capex of 90.3bn — an investment choice, not an urgent risk.
Leverage & Liquidity
Leverage warrants monitoring, with net debt / equity at 1.10x and interest coverage only at 0.74x.
At present, short-term debt accounts for 44.5% of total debt, cash equals 0.9% of debt, and total debt stands at 1,441.7bn.
Watchpoints
Net debt / equity stands at 1.10x, increasing balance-sheet pressure.
Interest coverage is 0.74x, leaving limited room to absorb financing costs.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 29.1bn in 2025, against investing cash flow of -67.0bn.
Post-investment cash flow was negative +37.9bn. Financing cash flow was negative +114.4bn.
CFO / net income was 0.05x.
After spending +90.3bn on fixed-asset investment, the business generated trailing free cash flow of −88.8bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with margins remain under pressure remaining the main constraint, with net margin down 1.6 pp. The next watchpoint is capital efficiency.
Watchpoint: Capital efficiency needs cycle context.
Key risk: profitability remains under pressure, with trailing-12M net margin at 3.22% after a 1.6pp decline versus the same period last year.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
1,077.7 | 1,065.1 | 1,340.0 | 1,057.0 | 940.6 |
|
Cost of Goods Sold
|
892.1 | 855.3 | 1,109.2 | 821.6 | 0.0 |
|
Gross Profit
|
185.6 | 209.8 | 230.8 | 235.4 | 174.9 |
|
Financial Expenses
|
43.9 | 43.3 | 46.2 | 37.5 | -35.1 |
|
Selling Expenses
|
4.5 | 4.9 | 6.0 | 6.1 | -7.5 |
|
General and Administrative Expenses
|
105.0 | 134.4 | 134.0 | 117.0 | -105.3 |
|
Operating Profit
|
34.6 | 30.2 | 51.1 | 79.6 | 38.3 |
|
Profit Before Tax
|
39.9 | 28.1 | 49.7 | 76.9 | 37.7 |
|
Net Income
|
31.5 | 21.7 | 39.4 | 60.2 | 29.3 |
|
Profit Attributable to Parent
|
31.5 | 21.7 | 39.4 | 60.2 | 29.4 |
|
Earnings per Share
|
7,007.00 | 191.00 | 347.00 | 530.00 | 371.00 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.